<div id="poce_contents" class="invest">
            <h2 id="sr-content">Investigations</h2>
            <div id="invest1">
               <div class="row">
                  <div class="col-md-9">
                     <h3 id="firstOrder">1st Tests to order</h3>
                  </div>
                  <div class="col-md-3 text-right">
                     <h3><a href="https://bestpractice.bmj.com/topics/en-gb/116/investigations#">
                        <span class="hidden-sm-down">
                        <span class="msg">VIEW ALL</span>
                        <span class="material-icons" role="button"><span></span><span></span></span>
                        </span>
                        </a>
                     </h3>
                  </div>
               </div>
               <div class="card mb-4">
                  <div class="card-block">
                     <div class="container">
                        <div id="5bedbdbc-d2e8-42df-913b-eb7c30d39fb4" class="row rowCondition">
                           <div class="accordion-toggle col-md-12 collapsed" data-toggle="collapse" data-target="#collapseTest-ctpa" aria-expanded="false">
                              <h3>CTPA</h3>
                           </div>
                        </div>
                        <div id="collapseTest-ctpa" class="row rowDetails collapse" aria-expanded="false" style="">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <ul>
                                          <li><strong>CPTA is the preferred investigation for definitive confirmation of PE. It is indicated in:</strong>
                                          <ul>
                                          <li><strong>Patients with suspected PE who are haemodynamically unstable at presentation</strong> (provided CTPA is immediately available and the patient is well enough to have it - in practice this is often not the case and echocardiography is used instead)</li>
                                          <li><strong>Patients who are classified as &lsquo;PE likely&rsquo; based on Wells (or Geneva) score.</strong></li>
                                          <li><strong>Patients who are classified as &lsquo;PE unlikely&rsquo; based on Wells or Geneva score but who have a positive D-dimer test. </strong>[NICE]</li>
                                          </ul>
                                          </li>
                                          <li><strong>Avoid CTPA if possible in pregnant womenc and younger patients</strong>, especially if PE can be ruled out by other non-invasive methods with less radiation exposure. [ARN]</li>
                                          <li><strong>PE does not need to be confirmed on CTPA prior to discharge in low-risk patients (PESI I-II or sPESI 0) who are suitable for outpatient management but it should be performed within 24 hours </strong>(if available) [BTS]</li>
                                          </ul>

                                          <div class="evidence-accordion">
                                             <div class="option">
                                                <input type="checkbox" id="toggle1" class="toggle" />
                                               <label class="title" for="toggle1">Evidence: Risks of CTPA
                                                </label>
                                                <div class="content">
                                                   <p><strong>Radiation from CT is considered to be a risk factor for cancer</strong></p>
                                                   <ul>
                                                      <li>In one study, a cohort of children with CT exposure was found to have a significantly higher incidence of leukemia and brain tumors later in life. Women in particular are also at significant risk due to the imaging of radiosensitive breast tissue during CTPA. [ACP]</li>
                                                      </ul>
                                                      <p><strong>The contrast dye used in CTPA for the evaluation of PE may cause nephropathy.</strong></p>
                                                      <ul>
                                                      <li>In a prospective study, 174 patients underwent CTPA, which demonstrated acute PE in 7%. Some 12% developed contrast-induced nephropathy including one patient with acute PE. Development of contrast-induced nephropathy was associated with an increased risk of severe renal failure and death within the subsequent 45 days</li>
                                                      </ul>
                                                      <p><strong>Repeated imaging is common which may magnify these risks.</strong></p>
                                                      <ul>
                                                      <li>In one study performed at a large academic center, at least one third of emergency department patients who had CTPE for the evaluation of PE underwent another CT for the same reason within 5 years. [KLINE]</li>
                                                      </ul>
                                                      <p><strong>More widespread use of CTPA may lead to overdiagnosis of subsegmental PEs that are often of little clinical significance </strong></p>
                                                      <ul>
                                                      <li>The diagnostic value and clinical significance of subsegmental defects identified on CTPA remains hotly debated. [ESC take-home messages doc].</li>
                                                      <li>Evidence suggests that there has been minimal or no associated change in patient outcomes despite the increased use of CTPA. It is thought that this is due to increased identification of less severe PEs (such as subsegmental PEs) that would not have previously been diagnosed and that may not be clinically relevant. [BOONE] [BRODER] [SOJ]</li>
                                                      <li>There is a lack of evidence to support decisions on whether or not to treat patients who have incidental PE detected by CTPA, although they probably should be treated if they have cancer and a proximal clot. [ESC take-home messages doc]</li>
                                                      <li>Potentially inappropriate overuse of CTPA results in increased risks to patients as well as higher costs.[ACP] <br /><strong>[END OF PANEL]</strong></li>
                                                      </ul>
                                                </div>
                                             </div>
                                          </div>
                                          <div class="evidence-accordion">
                                                <div class="option">
                                                   <input type="checkbox" id="toggle2" class="toggle" />
                                                  <label class="title" for="toggle2">Evidence: The predictive value of CTPA depends on the pre-test probability of PE
                                                   </label>
                                                   <div class="content">
                                                         <p><strong>The PIOPED II trial highlighted the influence of clinical probability on the predictive value of CTPA.</strong> [PIOPED]</p>
                                                         <ul>
                                                         <li>The negative predictive value for PE of a negative CTPA was dependent on pre-test clinical probability of PE as assessed by the Wells Score (96% for those with a low probability pre-test Wells Score and 89% for those with an intermediate probability score but only 60% for those with a high probability Wells score - based on the 3-level Wells Score)</li>
                                                         <li>Conversely the positive predictive value of a positive CTPA was high (92-96%) in patients with an intermediate or high probability pre-test Wells Score but only 58% in those with a low probability pre-test score.</li>
                                                         <li><strong>Therefore, clinicians should be particularly cautious in case of discrepancy between clinical judgement and the CTPA result.</strong> However a normal CTPA excludes a PE in a patient whose pre-test Wells or Geneva score categorised them as PE unlikely. [ESC]</li>
                                                         </ul>
                                                   </div>
                                                </div>
                                             </div>
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <ul>
                                          <li><strong>PE is confirmed by direct visualisation of thrombus in a pulmonary artery</strong>; appears as a partial or complete intraluminal filling defect</li>
                                          <li><strong>Signs of RV enlargement are: [CARD][ESC]</strong>
                                          <ul>
                                          <li>RV diameter/LV diameter &gt;0.9</li>
                                          </ul>
                                          </li>
                                          </ul>
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="14caec9e-585a-4706-bba5-c63ade784cc6" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-Echocardiography">
                              <h3>Echocardiography</h3>
                           </div>
                        </div>
                        <div id="collapseTest-Echocardiography" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <ul>
                                          <li><strong>Use echocardiography for haemodynamically unstable patients who cannot have CTPA</strong>. 
                                             <ul>
                                                   <li>If CTPA is not immediately available or the patient is too unwell to be moved, a bedside echocardiography should be performed.</li>
                                                   <li><strong>The presence of any signs of RV dysfunction is sufficiently suggestive of PE to confirm the diagnosis and justify emergency reperfusion </strong>treatment (usually thrombolysis). [ESC]</li>
                                                   </ul></li>
                                          
                                          </ul>

                                    <ul>
                                          <li><strong>Do not use echocardiography routinely in haemodynamically stable patients with suspected PE.</strong>
                                          <ul>
                                          <li>However, if it has been performed as part of the diagnostic work-up and shows evidence of RV dysfunction, consider further risk stratification by measuring a cardiac biomarker. [BTS]</li>
                                          </ul>
                                          </li>
                                          </ul>

                                    <ul>
                                          <li><strong>Echocardiography can also identify important alternative causes of shock</strong>, such as pericardial tamponade, acute valvular dysfunction, severe global or regional LV dysfunction, aortic dissection, or hypovolaemia.</li>
                                          </ul>

                                          
                                          

                                          <div id="tip_pitfall" class="card card-inverse p-3 mb-4">
                                                <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                                <div class="card-block">
                                                      <p><strong>A negative echocardiography does not exclude PE. [ESC]</strong></p>
                                                      <ul>
                                                      <li>The reported negative predictive value for PE is 40&ndash;50%</li>
                                                      </ul>
                                                      <p><strong>Assessment of RV function on echocardiography is not obligatory for the identification of low-risk patients who are suitable for outpatient management.</strong> [BTS]</p>
                                                      
                                                      <ul>
                                                      <li>However, if it has been performed as part of the diagnostic work-up for PE and shows evidence of RV dysfunction, consider measuring a cardiac biomarker to further risk stratify the patient. </li>
                                                      </ul>
                                                      
                                                </div>
                                             </div>
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <ul>
                                          <li>Abnormal RV ejection pattern (so-called <strong>&lsquo;60&ndash;60 sign&rsquo;</strong>) [ESC]</li>
                                          <li>Reduced contractility of the RV free wall compared with the RV apex <strong>(&lsquo;McConnell sign&rsquo;</strong>)[ESC]</li>
                                          <li>RV dilatation and hypokinesis</li>
                                          <li>RV diameter/LV diameter &gt;0.9</li>
                                          <li>Interventricular septal flattening and paradoxical leftward septal motion</li>
                                          <li>Presence of tricuspid regurgitation</li>
                                          <li>Presence of pulmonary hypertension (peak tricuspid jet velocity greater than 2.6m/s and loss of respirophasic IVC collapse.</li>
                                          <li>Mobile right heart thrombi can be detected by transthoracic or transoesophageal echocardiography (or by CT angiography) in less than 4% of unselected patients with PE. This finding essentially confirms the diagnosis of PE. This finding is associated with RV dysfunction and high early mortality. [ESC]</li>
                                          </ul>
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="7407daf9-7b93-46af-a743-a77d5bb05b9b" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-D-dimer">
                              <h3>D-dimer</h3>
                           </div>
                        </div>
                        <div id="collapseTest-D-dimer" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <ul>
                                          <li><strong>Request D-dimer testing in any haemodynamically stable patient whose Wells (or Geneva) Score categorises them as &lsquo;PE unlikely&rsquo; but who fails to fulfil all the PERC criteria.</strong> [RAJA] [ACP]<br /></li>
                                          <li><strong>Do not use D-dimer testing in patients </strong><strong>whose Wells (or Geneva) Score categorises them as &lsquo;PE likely&rsquo; </strong>&nbsp;as a negative result will not remove the need for further imaging. [RAJA] [ACP]</li>
                                          <li><strong>A normal plasma D-dimer level safely excludes PE</strong> in patients with an unlikely pretest probability of PE and no further investigation is required. [ACP][ESC][NICE][RAJA] The <strong>risk of PE within 3 months is &lt;1%</strong> in these patients. [CARRIER]</li>
                                          <li><strong>If a patient has a raised D-dimer level, start anticoagulation </strong>(unless contraindicated) <strong>and arrange CTPA to confirm or exclude PE </strong>(unless a concurrent DVT is suspected). [NICE] [ESC] [ACP]</li>
                                          <li><strong>D-dimer testing is highly sensitive (&gt;95%)</strong> in patients in whom pre-test probability suggests that PE is unlikely. [RAJA] However, its specificity is low and may decline with increasing patient age. [RAJA]</li>
                                          </ul>
                                          <div id="tip_pitfall" class="card card-inverse p-3 mb-4">
                                             <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                             <div class="card-block">
                                                <p><strong>Remember that a D-dimer level is a </strong><strong>continuous variable. </strong></p>
                                                <ul>
                                                <li>A low D-dimer does not mean no risk of PE and a slightly higher D-dimer does not mean a step increase in PE risk.</li>
                                                <li>The threshold value (check what value is used by your local laboratory) is the optimum for balancing sensitivity and specificity.</li>
                                                </ul>
                                                <p><strong>In practice, many people have a raised D-dimer without having a PE.</strong></p>
                                                <ul>
                                                <li>It is more frequently elevated in patients with cancer, in hospitalised patients, with increasing age, with acute inflammatory conditions and infection and during pregnancy. &nbsp;This should be taken into consideration if investigating these patient groups. [ESC] [NICE]</li>
                                                </ul>
                                                   
                                             </div>
                                          </div>

                                          
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <ul>
                                       <li>Elevated (>500 nanograms/mL) [NICE] but check the threshold used by your local laboratory)
                                             </li>
                                    </ul>
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="c15ae129-2788-4c0a-854b-23e5013bcc4b" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-c15ae129-2788-4c0a-854b-23e5013bcc4b">
                              <h3>Full Blood Count</h3>
                           </div>
                        </div>
                        <div id="collapseTest-c15ae129-2788-4c0a-854b-23e5013bcc4b" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <ul>
                                          <li>May indicate <strong>thrombocytopenia or anaemia</strong>. These patients are at an increased risk of complications from bleeding when taking an anticoagulant.</li>
                                          <li>Heparin therapy can be associated with <strong>heparin-induced thrombocytopenia</strong>; platelet count should be measured at baseline and regularly throughout treatment.</li>
                                          <li>May also indicate <strong>thrombocythaemia </strong>or <strong>polycythaemia </strong>which increase the risk of VTE.</li>
                                          </ul>
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>
                                       Baseline values
                                    </p>
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="81bdca5e-373b-4c57-bf7e-759e35cee5e9" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-ECG">
                              <h3>ECG</h3>
                           </div>
                        </div>
                        <div id="collapseTest-ECG" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <p><strong>An ECG is not diagnostic of PE but can be useful to support the diagnosis of PE or rule out other causes.</strong></p>
                                       <ul>
                                       <li>Can indicate right ventricular (RV) strain suggestive of PE.[NICE]</li>
                                       <li>A normal ECG does not rule out a PE. [NICE]</li>
                                       </ul>

                                       <div class="evidence-accordion">
                                          <div class="option">
                                             <input type="checkbox" id="toggle3" class="toggle" />
                                            <label class="title" for="toggle3">Evidence: Some ECG signs are predictors of a poor outcome
                                             </label>
                                             <div class="content">
                                                <ul>
                                                   <li>A systematic review and meta-analysis looked at the value of using ECG in predicting clinical deterioration and mortality in acute PE.</li>
                                                   <li>It found that ECG signs that were <strong>good predictors of a poor outcome</strong> included <strong>S1Q3T3, complete right bundle branch block, T-wave inversion, right axis deviation and atrial fibrillation.</strong> [DIGBY]<br />[END OF PANEL]</li>
                                                   </ul>
                                             </div>
                                          </div>
                                       </div>


                                       
                                      
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <ul>
                                          <li>Normal sinus rhythm</li>
                                          <li>Sinus tachycardia</li>
                                          <li>New right bundle branch block (complete or incomplete).</li>
                                          <li>QR pattern in V1</li>
                                          <li>S1Q3T3 pattern</li>
                                          <li>T wave inversion in V1-V4</li>
                                          <li>ST segment migration in V1 through V4</li>
                                          <li>Atrial arrhythmias, most frequently atrial fibrillation</li>
                                          <li>Non-specific ST-segment and T-wave abnormalities</li>
                                          <li>Right axis deviation</li>
                                          <li>P pulmonale. [ESC][ACP] [DIGBY]</li>
                                          </ul>
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="f9c06361-cf9d-4074-a302-3103886c6a95" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-urea">
                              <h3>Urea and Electrolytes</h3>
                           </div>
                        </div>
                        <div id="collapseTest-urea" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <ul>
                                          <li><strong>Check baseline renal function</strong>. Doses of some anticoagulants (e.g. low molecular weight heparin, fondaparinux, apixaban, rivaroxaban, dabigatran, edoxaban) may need to be adjusted in patients with renal impairment. [NICE]</li>
                                          <li>Renal function results<strong> can also be used to guide investigations.</strong> For example using CTPA in patients with severe renal impairment can risk contrast-induced nephropathy.</li>
                                          </ul>
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>
                                       Baseline values
                                    </p>
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="c58be6e8-b7b1-4246-b45c-b8946a85a90d" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-coagulation">
                              <h3>Coagulation studies</h3>
                           </div>
                        </div>
                        <div id="collapseTest-coagulation" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <ul>
                                          <li><strong>Order International normalised ratio (INR), prothrombin time (PT), and activated partial thromboplastin time (aPTT)</strong>. These are needed to establish baseline values before starting anticoagulation.</li>
                                          <li>Also aids decisions about the safety and choice of initial anticoagulation. [NICE]</li>
                                          </ul>
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>
                                       Baseline values
                                    </p>
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="b333c5a4-5cdf-4ffe-848d-e18dfb1402a3" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-liver">
                              <h3>Liver function tests</h3>
                           </div>
                        </div>
                        <div id="collapseTest-liver" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <ul>
                                       <li>
                                          Abnormal LFTs can influence the choice of anticoagulation
                                       </li>
                                    </ul>
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>
                                       Baseline values
                                    </p>
                                 </div>
                              </div>
                           </div>
                        </div>
                     </div>
                  </div>
               </div>
            </div>
            <div id="invest2">
               <div class="row">
                  <div class="col-md-9">
                     <h3 id="toConsider">Other tests to consider</h3>
                  </div>
                  <div class="col-md-3 text-right">
                     <h3><a href="https://bestpractice.bmj.com/topics/en-gb/116/investigations#">
                        <span class="hidden-sm-down">
                        <span class="msg">VIEW ALL</span>
                        <span class="material-icons" role="button"><span></span><span></span></span>
                        </span>
                        </a>
                     </h3>
                  </div>
               </div>
               <div class="card mb-4">
                  <div class="card-block">
                     <div class="container">
                        <div id="c693b37f-7352-44dc-bacf-76d0e25f94ac" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-c693b37f-7352-44dc-bacf-76d0e25f94ac">
                              <h3>ABG (arterial blood gas)</h3>
                           </div>
                        </div>
                        <div id="collapseTest-c693b37f-7352-44dc-bacf-76d0e25f94ac" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <ul>
                                       <li><strong>Do not perform an ABG if the oxygen saturations are within normal range on room air.</strong></li>
                                       </ul>
                                       <ul>
                                       <li><strong>Consider ABG in patients who have low oxygen saturations. </strong>However, be aware that it is of very limited diagnostic utility, either alone or in combination with other clinical variables, in suspected PE.[ROGER]</li>
                                       </ul>

                                       <div class="evidence-accordion">
                                          <div class="option">
                                             <input type="checkbox" id="toggle4" class="toggle" />
                                            <label class="title" for="toggle4">Evidence: ABG has a limited role in diagnosing PE
                                             </label>
                                             <div class="content">
                                                <ul>
                                                   <li>A PaO₂ &lt;80 mmHg (10.7 kPa), a PaCO₂ &lt;36 mmHg (4.6 kPa), or an abnormal alveolar-arterial gradient (A&ndash;aO₂) are not predictive of PE in patients suspected of having PE. [ROGER]</li>
                                                   <li>In patients with suspected acute PE with normal arterial blood gas (ABG) results, PE could not be excluded in 38% of those without cardiopulmonary disease or in 14% who had pre-existing cardiopulmonary disease. [PD]</li>
                                                   </ul>
                                             </div>
                                          </div>
                                       </div>
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>Hypoxaemia and hypocapnia may be suggestive of PE. [NICE]</p>
                                    
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="5547d291-eb12-412d-9ae7-2452a85e0e21" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-5547d291-eb12-412d-9ae7-2452a85e0e21">
                              <h3>CXR</h3>
                           </div>
                        </div>
                        <div id="collapseTest-5547d291-eb12-412d-9ae7-2452a85e0e21" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <p><strong>Not diagnostic of PE but may be </strong><strong>useful to support the diagnosis and is important to rule out other causes.</strong></p>
                                    <ul>
                                    <li>It is <strong>usually normal</strong> in a patient with a PE but an <strong>abnormal CXR does not rule out PE</strong> [NICE]</li>
                                    </ul>

                                    <div id="tip_pitfall" class="card card-inverse p-3 mb-4">
                                       <div class="card-block">
                                          <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                          
                                          <ul>
                                             <li>Pulmonary infarction secondary to PE can be difficult to distinguish from pneumonia on CXR.</li>
                                          </ul>
                                       </div>
                                    </div>

                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>Usually normal but may show atelectasis, pleural effusion elevation of hemidiaphragm can be suggestive of a PE. [NICE]</p>
                                   
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="db594f10-22e8-4c49-ac9a-9e99f377feeb" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-db594f10-22e8-4c49-ac9a-9e99f377feeb">
                              <h3>Lower limb compression venous ultrasound</h3>
                           </div>
                        </div>
                        <div id="collapseTest-db594f10-22e8-4c49-ac9a-9e99f377feeb" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <ul>
                                       <li><strong>Use lower limb compression venous ultrasound to</strong> <strong>investigate patients suspected of having a concurrent DVT.</strong>
                                         <ul>
                                       <li>Finding a proximal DVT in patients suspected of having PE is considered sufficient to start anticoagulant treatment without further investigation. [ESC]</li>
                                       </ul></li>
                                       
                                       </ul>

                                       <div class="evidence-accordion">
                                          <div class="option">
                                             <input type="checkbox" id="toggle5" class="toggle" />
                                            <label class="title" for="toggle5">Evidence: Lower limb ultrasound has high sensitivity/specificity for DVT
                                             </label>
                                             <div class="content">
                                                <ul>
                                                <li>Lower limb compression venous ultrasound has a sensitivity >90% and a specificity of approximately 95% for symptomatic DVT and shows a DVT in 30–50% of patients with PE. [ESC]</li>
                                                </ul>
                                             </div>
                                          </div>
                                       </div>
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>
                                       Inability to fully compress lumen of vein using ultrasound transducer
                                    </p>
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="8a294944-2391-435d-9a93-ba4cee67e099" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-8a294944-2391-435d-9a93-ba4cee67e099">
                              <h3>Cardiac biomarker</h3>
                           </div>
                        </div>
                        <div id="collapseTest-8a294944-2391-435d-9a93-ba4cee67e099" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <p><strong>The cardiac biomarkers high sensitivity troponin (either I or T), NT-proBNP or BNP are not used in diagnosing PE but can aid prognostic assessment.</strong> [BTS]</p>
                                 <ul>
                                 <li>They can be used in combination with risk stratification scoring (PESI/sPSEI) to <strong>guide decisions about early discharge for low-risk patients</strong>. [ESC]</li>
                                 </ul>
                                 <p><strong>Measure a cardiac biomarker in a patient with a confirmed or highly suspected PE (positive D-dimer or Wells score &gt;4) only if all three of the following criteria are met: [BTS]</strong></p>
                                 <ul>
                                 <li>risk stratification puts the patient in the low-risk group (PESI I-II or sPESI 0) AND</li>
                                 <li>incidental RV strain was identified on CTPA or echocardiography performed as part of the diagnostic work-up AND</li>
                                 <li>the patient is considered potentially suitable for outpatient management [BTS]
                                    <ul>
                                       <li>If the cardiac biomarker is normal, you can consider the patient for discharge (after appropriate discussion with a senior). [BTS]</li>
                                       <li>If cardiac biomarker is elevated, admit the patient for observation. [BTS]</li>
                                       </ul>

                                 </li>
                                 </ul>
                                 <p><strong>Do not use routinely to risk stratify patients.</strong></p>
                                 <p><strong>Seek senior review if there is an incidental finding of an elevated troponin in a patient with a low-risk PE (PESI I or II/sPESI 0)</strong></p>
                                 <ul>
                                 <li>An alternative cause for elevated troponin should be considered. [BTS]</li>
                                 </ul>

                                 <div class="evidence-accordion">
                                    <div class="option">
                                       <input type="checkbox" id="toggle6" class="toggle" />
                                      <label class="title" for="toggle6">Evidence: Elevated cardiac biomarkers predict a worse outcome
                                       </label>
                                       <div class="content">
                                          <p><strong>Elevated plasma troponin levels on admission have been reported to be associated with a worse prognosis. </strong><strong></strong></p>
                                       <ul>
                                       <li><strong><em>A meta-analysis covering a total or 1985 patients showed elevated cardiac troponin I or T concentrations in approximately 50% of the patients with acute PE. Elevated troponin concentrations were associated with higher mortality both in unselected patients and haemodynamically stable patients. &nbsp;[BECATTINI]</em></strong></li>
                                       </ul>
                                       <p><strong>Low levels of BNP or NT-proBNP can identify patients with a favourable short-term outcome based on their high negative predictive value.</strong> [COUTANCE] </p>
                                       <ul>
                                       <li>The plasma levels of BNP and NT-proBNP reflect the severity of haemodynamic compromise and (presumed) RV dysfunction in acute PE. Right ventricular pressure overload is associated with increased myocardial stretch, which leads to the release of BNP or NT-proBNP and therefore raised plasma levels. [ESC]</li>
                                       <li>A meta-analysis found that 51% of 1132 unselected patients with acute PE had elevated BNP or NT-proBNP concentrations on admission. These patients had a 10% risk of early death and a 23% risk of an adverse outcome.[HENZLER]</li>
                                       </ul>
                                       </div>
                                    </div>
                                 </div>



                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>
                                       Raised cardiac marker is associated with worse prognosis in PE [ESC][BTS][BECATTINI]
                                    </p>
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="8509fe81-de45-4417-968e-7ad9a5525aae" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-8509fe81-de45-4417-968e-7ad9a5525aae">
                              <h3>Ventilation-perfusion (V/Q) scan</h3>
                           </div>
                        </div>
                        <div id="collapseTest-8509fe81-de45-4417-968e-7ad9a5525aae" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <ul>
                                       <li><strong>A V/Q scan can be performed in patients with an elevated D-dimer and a contraindication to CTPA</strong> (<strong>such as pregnancy, renal impairment or contrast allergy)</strong>. [ESC] [ACP] [NICE]</li>
                                       <li><strong>V/Q may be preferred over CTPA in some patient groups to avoid unnecessary radiation</strong>, particularly in younger and female patients in whom CTPA may raise the lifetime risk of cancer [ESC] [ACP]</li>
                                       </ul>

                                       <div id="tip_pitfall" class="card card-inverse p-3 mb-4">
                                          <div class="card-block">
                                             <h3 class="card-title">Practical tip / Pitfall panel</h3>
                                             <p class="card-text"><strong>A V/Q scan is of limited use in patients with significant underlying lung disease, left ventricular failure or congestive cardiac failure. [ESC]
                                             </strong></p>
                                          </div>
                                       </div>

                                       <div class="evidence-accordion">
                                          <div class="option">
                                             <input type="checkbox" id="toggle7" class="toggle" />
                                            <label class="title" for="toggle7">Evidence: Ruling out PE with a V/Q scan
                                             </label>
                                             <div class="content">
                                                <p><strong>Evidence supports the potential use of V/Q scanning as the first-line imaging test for PE in younger patients.</strong></p>
                                             <ul>
                                             <li>V/Q lung scintigraphy has been shown to be diagnostic (with either normal or high-probability findings) in approximately 30&ndash;50% of emergency ward patients with suspected PE. The proportion of diagnostic V/Q scans was higher in patients with a normal chest X-ray. [DIDIER]</li>
                                             <li>The number of patients with inconclusive findings on V/Q scan may be reduced by taking into account clinical probability. Evidence shows that patients with a negative lung scan and low clinical probability of PE have a low prevalence of confirmed PE. The negative predictive value of this combination is further increased by the absence of a DVT on lower limb compression venous ultrasound. [PIOPE90][SORSH]</li>
                                             </ul>
                                             </div>
                                          </div>
                                       </div>

                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>
                                       PE likely when an area of ventilation is not perfused [ESC]
                                    </p>
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="0758aeee-c67a-4e43-826a-b58a00e2986f" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-0758aeee-c67a-4e43-826a-b58a00e2986f">
                              <h3>Further investigation for unprovoked PE</h3>
                           </div>
                        </div>
                        <div id="collapseTest-0758aeee-c67a-4e43-826a-b58a00e2986f" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <p><strong>An unprovoked PE is a PE in a patient who had no pre-existing, transient provoking risk factor in the prior 3 months. </strong>[NICE]</p>
                                 <ul>
                                 <li><strong>Provoking risk factors include: surgery; trauma; significant immobility (bedbound, unable to walk unaided or likely to spend a substantial proportion of the day in bed or in a chair); pregnancy or puerperium; use of oral contraceptive/hormone replacement therap). </strong></li>
                                 </ul>
                                 <p><strong>An unprovoked PE may be suggestive of an underlying condition so further investigations are sometimes warranted.</strong></p>
                                 <p><strong>Undiagnosed cancer</strong></p>
                                 <p><strong>Offer any patient diagnosed with an unprovoked PE who is not already known to have cancer the following initial investigations:</strong> [NICE]</p>
                                 <ul>
                                 <li>A physical examination (guided by the patient&rsquo;s full history)</li>
                                 <li>CXR</li>
                                 <li>Blood tests (full blood count, serum calcium and liver function tests)</li>
                                 <li>Urinalysis</li>
                                 </ul>
                                 <p><strong>Consult local guidelines when deciding whether to undertake additional investigations for cancer </strong></p>
                                 <ul>
                                 <li>NICE recommends considering a CT scan of the abdomen and pelvis (and a mammogram for women) in any patient over 40 years with a first unprovoked PE who does not have signs or symptoms of cancer based on initial investigation. [NICE]</li>
                                 <li>However, in clinical practice it is common to investigate further only if there are signs or symptoms of cancer in the history or examination or abnormalities picked up on initial investigations. Further investigation with CT scan or mammogram can be considered but the sensitivity is low and many local guidelines do not recommend these tests.</li>
                                 </ul>

                                 <div class="evidence-accordion">
                                    <div class="option">
                                       <input type="checkbox" id="toggle8" class="toggle" />
                                      <label class="title" for="toggle8">Evidence: Evidence is weak to support screening for cancer after unprovoked PE
                                       </label>
                                       <div class="content">
                                          <p><strong>The evidence supporting screening for undiagnosed cancer after unprovoked VTE is inconclusive.</strong></p>
                                       <ul>
                                       <li>A screening strategy that was proposed in the SOMIT trial included pelvic and abdominal CT combined with mammography and sputum cytology. This was recommended as the most effective and least harmful approach for patients. </li>
                                       <li>However, no 5-year survival benefit was found when this approach was compared with basic clinical evaluation. [PRINS][DOORMAAL]</li>
                                       </ul>
                                       
                                       </div>
                                       
                                    </div>
                                 </div>
                                 <p><strong><u>Thrombophilia testing</u></strong></p>
                                       <p><strong>Consider testing for hereditary thrombophilia in a patient who has had an unprovoked PE and who has a first-degree relative who has had a DVT or PE if it is planned to stop anticoagulation treatment.</strong></p>
                                       <ul>
                                       <li>Do not offer thrombophilia testing to patients who are continuing anticoagulation treatment</li>
                                       </ul>
                                       <p><strong>Consider testing for antiphospholipid antibodies in patients who have had an unprovoked PE if it is planned to stop anticoagulation treatment.</strong></p>
                                       <p><strong>Do not routinely offer thrombophilia testing to first-degree relatives of people with a history of PE and thrombophilia.</strong> [NICE]</p>


                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>
                                       
                                    </p>
                                 </div>
                              </div>
                           </div>
                        </div>
                        
                     </div>
                  </div>
               </div>
            </div>
            <div id="invest3">
               <div class="row">
                  <div class="col-md-9">
                     <h3 id="emerging">Emerging tests</h3>
                  </div>
                  <div class="col-md-3 text-right">
                     <h3><a href="https://bestpractice.bmj.com/topics/en-gb/116/investigations#">
                        <span class="hidden-sm-down">
                        <span class="msg">VIEW ALL</span>
                        <span class="material-icons" role="button"><span></span><span></span></span>
                        </span>
                        </a>
                     </h3>
                  </div>
               </div>
               <div class="card">
                  <div class="card-block">
                     <div class="container">
                        <div id="18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-18f09885-71b3-436a-b52e-e6e8e9b687b1">
                              <h3>Age adjusted D-dimer testing</h3>
                           </div>
                        </div>
                        <div id="collapseTest-18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <p><strong>Recent evidence suggests using age-adjusted cut-offs can improve the performance of D-dimer testing in patients over 50 years[ACP][ESC][SCHOUTEN]</strong></p>
                                 <ul>
                                 <li>It's specificity is low and may decline with increasing patient age.[RAJA]</li>
                                 </ul>
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>
                                       
                                    </p>
                                 </div>
                              </div>
                           </div>
                        </div>
                        <div id="18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowCondition">
                           <div class="accordion-toggle col-md-12" data-toggle="collapse" data-target="#collapseTest-18f09885-71b3-436a-b52e-e6e8e9b687b1">
                              <h3>Magnetic resonance angiography</h3>
                           </div>
                        </div>
                        <div id="collapseTest-18f09885-71b3-436a-b52e-e6e8e9b687b1" class="row rowDetails collapse">
                           <div class="col-md-12">
                              <div class="row rowHead hidden-sm-down">
                                 <div class="col-md-8">Test</div>
                                 <div class="col-md-4">Result</div>
                              </div>
                              <div class="row">
                                 <div class="col-md-8">
                                    <span class="hidden-md-up">Test</span>
                                    <p><strong>The hypothesis is that a </strong><strong>that a negative MRA combined with the absence of proximal DVT on lower limb compression venous ultrasound may safely rule out clinically significant PE. [ESC]</strong></p>
                                 <ul>
                                 <li><strong> MRA has been shown to be promising but is not yet ready for clinical practice </strong>due to its low sensitivity, high proportion of inconclusive scans, and low availability in most emergency settings. [ESC]</li>
                                 <li>This is currently being tested in a multicentre outcome study. [ESC]</li>
                                 </ul>
                                 </div>
                                 <div class="col-md-4">
                                    <span class="hidden-md-up">Result</span>
                                    <p>
                                       
                                    </p>
                                 </div>
                              </div>
                           </div>
                        </div>
                     </div>
                  </div>
               </div>
            </div>
            
         </div>